SII Hopeful To Launch Its 2nd Vaccine 'COVOVAX' By June

The Serum Institute of India (SII) chief Adar Poonawalla on January 30 announced of hopefully launching ‘COVOVAX’ as the second COVID-19 vaccine in June 2021. Poonawalla also claimed that the Novavax vaccine that has partnered with the US is currently undergoing trials and has shown excellent efficiency. While DCGI approved vaccines Covishield and Covaxin were used in India, the COVOVAX would become the third vaccine developed by India if approved.